EcoDrugPlus

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSOKIG00005014797
Gene Symbol: LOC109869839
3 Cross references
199 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1

Ensembl ID : ENSOKIG00005026084
Gene Symbol: LOC109871724
3 Cross references
202 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1-Like

Ensembl ID : ENSOKIG00005039520
Gene Symbol: LOC109875261
3 Cross references
202 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSOKIG00005037732
Gene Symbol: LOC109906056
3 Cross references
193 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSOKIG00005014182
Gene Symbol: LOC109868169
3 Cross references
244 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSOKIG00005008917
Gene Symbol: LOC109880653
2 Cross references
149 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2-Like

Ensembl ID : ENSOKIG00005033353
Gene Symbol: LOC109874670
3 Cross references
199 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSOKIG00005047927
Gene Symbol: LOC109875678
3 Cross references
197 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSOKIG00005029245
Gene Symbol: LOC116353892
2 Cross references
202 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSOKIG00005026041
Gene Symbol: LOC109892675
3 Cross references
198 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233

Ensembl ID : ENSOKIG00005017184
Gene Symbol: LOC109890491
3 Cross references
218 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3

Ensembl ID : ENSOKIG00005043878
Gene Symbol: LOC109864461
2 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).